Search

Researchers from the University of Tabuk in Saudi Arabia have investigated the use of silver-iron nanoparticles supported on titanium and zirconium dioxides as catalysts for the photodegradation of drug molecules. The materials were prepared using impregnation and characterized using various techniques. The nanoparticles showed high activity in the photodegradation of ibuprofen, acetaminophen, and amoxicillin, with mineralization rates of 98%. Additionally, the catalysts demonstrated significant resistance to corrosion in a strongly acidic medium. This research provides insights into the potential applications of these nanoparticles in drug development and anti-corrosive agents. [Extracted from the article]

A patent application titled "Methods And Related Compositions For The Treatment Of Cancer" has been published online. The inventor, Ilya Rachman, highlights the need for additional cancer treatments that can better target drug-resistant tumors and bypass the diversity of cancer cells. The patent application describes various embodiments, including methods of treating cancer by administering a composition comprising a micelle construct attached to an inhibitor of NF-kB, as well as pharmaceutical compositions and nanoconjugates for cancer treatment. The patent application also mentions specific cancers such as colon cancer, breast cancer, brain cancer, and ovarian cancer. [Extracted from the article]

Researchers at Hubei University of Chinese Medicine in Wuhan, China have developed a biosensor that can rapidly and accurately detect estrogen receptor alpha (ER alpha) protein, an important biomarker in breast cancer diagnosis and treatment. The biosensor utilizes a drug molecule-modified graphene field-effect transistor (FET) to capture and distinguish ER alpha-positive from ER alpha-negative protein. The sensor demonstrated a low detection limit and fast response time, making it a promising tool for ultrasensitive and rapid detection of ER alpha protein without the need for antibody labeling. This research has been peer-reviewed and published in Analytical Chemistry. [Extracted from the article]

A patent application titled "Natural-Polyphenols-Based Multi-Stage Porous Hydrogel Sustained Release Drug Delivery System And Its Preparation Method" has been published online by the US Patent and Trademark Office. The patent application describes a new drug delivery system using hydrogels, which are polymer materials that can absorb water and maintain their structure. The system aims to achieve continuous and stable drug release by adjusting the structure of hydrogels. The invention utilizes a natural polyphenols-based supramolecular filler to regulate the release of different kinds of drugs. The system has the potential to be cost-effective and has no side effects. [Extracted from the article]

A study conducted by researchers at University Gadjah Mada in Yogyakarta, Indonesia, explored the interactions between drug molecules and silicon-doped fullerenes using density functional theory calculations. The results showed that drug molecules could be chemisorbed in Si-doped fullerenes, which have more negative adsorption energy and lower formation energy compared to undoped fullerenes. These findings have implications for future drug delivery applications. The study was published in the Indonesian Journal of Chemistry. [Extracted from the article]

A recent study conducted at Chiba University in Japan has reported findings in the field of supramolecular research. The study focused on the encapsulation of drug molecules in a unique multicomponent supramolecular structure called the drug/(PEG/γ-CD-PPRX) complex. The researchers developed a sealed-heating preparation method to obtain a hexagonal-columnar (HC) form of the complex. The study found that the encapsulation efficiency of the guest drugs in the HC form was influenced by factors such as vapor pressure and molecular size. These findings contribute to a better understanding of the complexation behavior of guest molecules and offer insights into the fabrication of novel supramolecular structures. [Extracted from the article]

A recent study conducted by researchers at Tianjin University in China explores the use of graphene materials as drug carriers in drug delivery systems. The study focuses on the interaction between graphene and benzene ring structures, which are commonly found in organic drug molecules. The researchers propose an experimental method for measuring the adhesion force between a single phenyl and graphene, and they observe that the adhesion force decreases with increasing environmental pH. Molecular dynamics simulations show that the change in pH affects the electrostatic potential distribution on the graphene surface, leading to a shift from attractive to repulsive forces between benzene and graphene. The study also establishes a molecular dynamics model for the adsorption and desorption capacities of benzene molecules on graphene surfaces under different ion quantities. The researchers find that benzene molecules achieve full adsorption on the graphene surface with 10 to 20 hydrogen ions, and full desorption with 10 to 20 hydroxide ions. This research provides valuable insights into the molecular mechanics of benzene and graphene interactions, which can contribute to the development of more effective drug delivery systems. [Extracted from the article]

A research team from Chiba University in Japan has developed a novel approach for preparing supramolecular polymers (SPs) at high concentrations. SPs are molecular assemblies composed of non-covalently bonded small molecules and have high recyclability. However, the formation of crystalline polymorphic states can reduce the solubility of drug molecules. To overcome this issue, the researchers used a supramolecular coformer approach, which significantly improved the solubility of the drug molecule without affecting its ability to form SPs. This approach has the potential to facilitate large-scale production of SPs and contribute to the development of recyclable plastics. [Extracted from the article]

Keywords: Oviedo; Spain; Europe; Carbon Nanotubes; Drug Development; Drug Molecules; Drugs and Therapies; Emerging Technologies; Health and Medicine; Nanotechnology; Nanotubes EN Oviedo Spain Europe Carbon Nanotubes Drug Development Drug Molecules Drugs and Therapies Emerging Technologies Health and Medicine Nanotechnology Nanotubes 1473 1473 1 10/30/23 20231103 NES 231103 2023 NOV 3 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Fresh data on Nanotechnology - Carbon Nanotubes are presented in a new report. According to the news reporters, the research concluded: "Drug molecules encapsulated in modified nanotubes produce distinctive features in the density of states that can be used to sense and distinguish them from other types of molecules.". [Extracted from the article]

In particular we considered as drug molecules favipiravir (T705, an antiviral molecule) and 5-fluorouracil (5FU, an anticancer molecule) and, on the other hand, pure fullerenes (C-24, B12N12, Ga12N12) and doped fullerenes (C23B, CB11N12) are considered as nanocarriers." The optical absorption properties of the above mentioned drug molecules and their carrier nanostructures in the free and bound states are obtained by a TD-DFT method, in gas phase and in aqueous solution. Keywords: Monserrato; Italy; Europe; Anticancer Agents; Cancer; Cancer Therapy; Drug Development; Drug Molecules; Drugs and Therapies; Emerging Technologies; Fullerenes; Health and Medicine; Nanostructural; Nanostructures; Nanotechnology; Oncology; Protective Agents EN Monserrato Italy Europe Anticancer Agents Cancer Cancer Therapy Drug Development Drug Molecules Drugs and Therapies Emerging Technologies Fullerenes Health and Medicine Nanostructural Nanostructures Nanotechnology Oncology Protective Agents 1187 1187 1 09/04/23 20230908 NES 230908 2023 SEP 5 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- A new study on Nanotechnology - Nanostructures is now available. [Extracted from the article]

Keywords: Chiba; Japan; Asia; Supramolecular Research; Alkenes; Drug Development; Drug Molecules; Drugs and Therapies; Emerging Technologies; Ethylene Glycols; Health and Medicine; Hydrocarbons; Nanotechnology; Organic Chemicals; Polyenes; Polyethylene Glycols; Polyethylenes; Supramolecular EN Chiba Japan Asia Supramolecular Research Alkenes Drug Development Drug Molecules Drugs and Therapies Emerging Technologies Ethylene Glycols Health and Medicine Hydrocarbons Nanotechnology Organic Chemicals Polyenes Polyethylene Glycols Polyethylenes Supramolecular 636 636 1 08/28/23 20230901 NES 230901 2023 SEP 1 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- New research on Nanotechnology - Supramolecular Research is the subject of a report. For more information on this research see: Vapor-phase-mediated Encapsulation of Guest Drug Molecules In the Hexagonal Columnar Form Structure of Polyethylene Glycol/& Gamma;-cyclodextrin-polypseudorotaxane. [Extracted from the article]

Treating cancer cells with a composition comprising at least one nanoparticle comprising at least one anti-inflammatory protein, wherein the at least one anti-inflammatory protein comprises an alpha-1 acid glycoprotein (AGP) may be done prior to or simultaneous with treating said cancer cells with an anti-cancer, chemotherapeutic drug. Keywords: Anticancer Agents; Breast Cancer; Cancer; Chemotherapy; Drug Development; Drug Molecules; Drug Resistance; Drugs and Therapies; Emerging Technologies; Genetics; Glycoconjugates; Glycoproteins; Health and Medicine; Inflammation; Nanoparticles; Nanotechnology; Oncology; Patent Application; Peptides and Proteins; Protective Agents; Therapeutics; Therapy; Women's Health EN Anticancer Agents Breast Cancer Cancer Chemotherapy Drug Development Drug Molecules Drug Resistance Drugs and Therapies Emerging Technologies Genetics Glycoconjugates Glycoproteins Health and Medicine Inflammation Nanoparticles Nanotechnology Oncology Patent Application Peptides and Proteins Protective Agents Therapeutics Therapy Women's Health 1339 1339 1 08/28/23 20230829 NES 230829 2023 AUG 29 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors ALGHAMDI, Waleed M., ALHASAN, Ali H. (Riyadh, SA); ALHINDI, Yasser (Riyadh, SA); ALMALIK, Abdulaziz (Riyadh, SA); FARDOUS, Roa' (Riyadh, SA); OMAR, Haneen (Riyadh, SA), filed on October 19, 2022, was made available online on August 10, 2023, according to news reporting originating from Washington, D.C., by NewsRx correspondents. As described and claimed herein, the Inventors have devised an anti-inflammatory protein alpha-1 acid glycoprotein (AGP) decorated into HA NPs can be an alternative approach to modulate MDR via turning hot tumors into cold tumors and subsequently restoring their drug sensitivity and preventing their invasiveness. [Extracted from the article]

Keywords: Gujarat; India; Asia; Antibacterials; Antibiotics; Antimicrobials; Drug Development; Drug Molecules; Drugs and Therapies; Emerging Technologies; Health and Medicine; Ionic Liquids; Nanocarriers; Nanotechnology; Solvents EN Gujarat India Asia Antibacterials Antibiotics Antimicrobials Drug Development Drug Molecules Drugs and Therapies Emerging Technologies Health and Medicine Ionic Liquids Nanocarriers Nanotechnology Solvents 1280 1280 1 08/21/23 20230825 NES 230825 2023 AUG 25 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Current study results on Nanotechnology - Nanocarriers have been published. The mathematical drug release models show a sustainable release behaviour of the SMX drug molecules from the micellar matrix. [Extracted from the article]

Kolkata, Kolkata, India, Asia, Anticancer Agents, Cancer, Cancer Therapy, Drug Development, Drug Molecules, Drugs and Therapies, Emerging Technologies, Health and Medicine, Nanoassemblies, Nanonetworks, Nanotechnology, Oncology, Protective Agents Keywords: Kolkata; India; Asia; Anticancer Agents; Cancer; Cancer Therapy; Drug Development; Drug Molecules; Drugs and Therapies; Emerging Technologies; Health and Medicine; Nanoassemblies; Nanonetworks; Nanotechnology; Oncology; Protective Agents EN Kolkata India Asia Anticancer Agents Cancer Cancer Therapy Drug Development Drug Molecules Drugs and Therapies Emerging Technologies Health and Medicine Nanoassemblies Nanonetworks Nanotechnology Oncology Protective Agents 153 153 1 08/07/23 20230808 NES 230808 2023 AUG 8 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on Cancer have been presented. [Extracted from the article]

They trained the network on known protein-drug interactions, which allowed it to learn to associate specific features of the proteins with drug-binding ability, without having to calculate the 3D structure of any of the molecules. Amino Acids, Artificial Intelligence, Drug Development, Drug Molecules, Drugs and Therapies, Emerging Technologies, Health and Medicine, Machine Learning, Massachusetts Institute of Technology, Peptides, Proteins, Technology Keywords: Amino Acids; Artificial Intelligence; Drug Development; Drug Molecules; Drugs and Therapies; Emerging Technologies; Health and Medicine; Machine Learning; Massachusetts Institute of Technology; Peptides; Proteins; Technology EN Amino Acids Artificial Intelligence Drug Development Drug Molecules Drugs and Therapies Emerging Technologies Health and Medicine Machine Learning Massachusetts Institute of Technology Peptides Proteins Technology 1160 1160 1 06/26/23 20230627 NES 230627 2023 JUN 30 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- CAMBRIDGE, MA - Huge libraries of drug compounds may hold potential treatments for a variety of diseases, such as cancer or heart disease. [Extracted from the article]

Our news correspondents obtained a quote from the research from McGill University: "Periodic Disturbance Mixer (PDM), Staggered Herringbone Mixer (SHM) and ring micromixer microchannel designs increase the mixing rate and nanoprecipitation. Keywords: Biotechnology; Cancer; Cancer Gene Therapy; Drug Delivery Systems; Drug Development; Drug Molecules; Drugs and Therapies; Emerging Technologies; Gene Therapy; Health and Medicine; Liposomes; Nanoparticles; Nanotechnology; Oncology; Pharmaceuticals EN Biotechnology Cancer Cancer Gene Therapy Drug Delivery Systems Drug Development Drug Molecules Drugs and Therapies Emerging Technologies Gene Therapy Health and Medicine Liposomes Nanoparticles Nanotechnology Oncology Pharmaceuticals 20 20 1 04/24/23 20230424 NES 230424 2023 APR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- Investigators discuss new findings in cancer gene therapy. [Extracted from the article]

Keywords: Antidepressants; Drug Development; Drug Molecules; Drugs and Therapies; Emerging Technologies; Health and Medicine; Nanosystems; Nanotechnology EN Antidepressants Drug Development Drug Molecules Drugs and Therapies Emerging Technologies Health and Medicine Nanosystems Nanotechnology 2818 2818 1 04/03/23 20230407 NES 230407 2023 APR 7 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Investigators discuss new findings in nanosystems. Antidepressants, Drug Development, Drug Molecules, Drugs and Therapies, Emerging Technologies, Health and Medicine, Nanosystems, Nanotechnology. [Extracted from the article]

The method according to claim 14, wherein the selecting the candidate drug molecules comprises: determining, for each of the plurality of drug category sets, a candidate drug molecule with a highest activity information in a drug category set; and performing, for each of the determined candidate drug molecules, weighted summation on activity information, molecular docking information, and a drug property of the determined candidate drug molecule, to obtain comprehensive drug information of the determined candidate drug molecule; and ranking, based on comprehensive drug information of the determined candidate drug molecules, the determined candidate drug molecules in a descending order, and selecting the target drug molecules based on a result of the ranking. "Drug screening is a technology for screening target drug molecules having reference value for some diseases (for example, polycystic ovarian syndrome) from a large quantity of drug molecules. [Extracted from the article]

Keywords: Varanasi; India; Asia; Carbon; Drug Carriers; Drug Delivery Systems; Drug Development; Drug Molecules; Drugs and Therapies; Emerging Technologies; Fullerenes; Health and Medicine; Nanocages; Nanotechnology EN Varanasi India Asia Carbon Drug Carriers Drug Delivery Systems Drug Development Drug Molecules Drugs and Therapies Emerging Technologies Fullerenes Health and Medicine Nanocages Nanotechnology 730 730 1 03/24/23 20230224 NES 230224 2023 FEB 24 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- A new study on Nanotechnology - Nanocages is now available. However, the target molecule when adsorbs over the surface of B12N12 nanocage then its adsorption energy is-20.659 kcal/mol for the most favorable configuration in the gas phase, which suggests that B12N12 nanocage can be used as an effective drug carrier for target molecule. [Extracted from the article]